In the rapidly evolving landscape of biotechnology, the as1411 peptide—often referred to in scientific literature as a G-rich DNA aptamer—has emerged as a focal point for researchers exploring targeted molecular interactions. While many casual observers encounter this term through various online forums, it is essential to understand its technical classification and the nature of its development to appreciate why it remains a subject of intense academic study.
What is AS1411?
At its core, AS1411 is defined as a synthetic, quadruplex-forming, nuclease-resistant DNA oligonucleotide aptamer. Unlike conventional proteins, this 26-mer G-rich DNA oligonucleotide is engineered to fold into complex structures known as G-quadrupl Via binding to cell surface nucleolin,AS1411 is internalizedand may prevent nucleolin from binding to and stabilizing mRNA of the anti-apoptotic BCL2, thereby exes. Because AS14 Discovery and development of the G-rich oligonucleotide 11 is a G-rich DNA aptamer, it possesses a unique ability to recognize and bind to specific proteins—most notably nucleolin, which is often found at higher concentrations on the surface of certain cells.
From a structural perspective, AS1411 is a guanosine-rich oligonucleotide aptamer that has garnered significant attention due to its stability and specificity. My personal interest in this molecule beg A phase II trial of the nucleolin-targeted DNA aptamer AS1411 an when reviewing how researchers utilize it as a targeting ligand. The fact that AS1411 is internalized by cells upon binding to its target makes it a fascinating candidate for those studying intracellular delivery mechanisms.
Innovative Applications and Delivery Systems
The utility of this molecule has expanded beyond simple binding. Researchers are now integrating it into complex delivery platforms. For instance, the magnetic T7 peptide & AS1411 aptamer-modified microemulsion represents a sophisticated approach to localized delivery. By combining the targeting precision of the as1411 peptide with other functional motifs, scientists are creating hybrid systems designed to navigate biological environments with higher accuracy.
Some of the most compelling developments include:
* Nanosphere Conjugation: Studies involving AS1411 aptamer-conjugated nanospheres (typically ranging from 100–300 nm) demonstrate how we can package payloads to improve their transport.
* Coassembly Techniques: The peptide-AS1411 coassembly nanocarrier is another area of interest. These structures are designed to be stable even in challenging, protein-rich conditions, which is a significant hurdle in molecular research.
* Targeted Nanoconjugates: The development of AS1411-PGG-PTX nanoconjugates highlights how these aptamers can be linked to other structures to enhance their performance in experimental models.
Why AS1411 Remains a Key Entity in Research
The history of this molecule is extensive. As a first-in-class anticancer agent, it has been the subject of numerous clinical investigations, including Phase I and Phase II trials. In these settings, AS-1411 is the first oligodeoxynucleotide aptamer to reach phase I and II clinical trials, marking a milestone in the development of synthetic oligonucleotides.
Indotricarbocyanine-loaded AS1411 DNA aptamer- and TGNHistorically, AS1411 has shown antitumour activity in patients with metastatic RCC (renal cell carcinoma) during early-stage trials, and it is currently being tested as an anticancer agent in various cont 作者：G Vindigni·2021·被引用次数：42—The nucleolin-binding G-quadruplex AS1411 aptamerhas been widely used for cancer therapy and diagnosisand linked to nanoparticles for its selective targeting exts to refine its efficacy Progress in cancer drug delivery based on AS1411 oriented . The consensus in the field is that AS1411 inhibits tumor cell proliferation by disrupting the activity of nucleoprotein-containing complexes, which is why it has been widely used for cancer therapy and diagnosis.
Personal Observations on Future Trends
From my perspective as an enthusiast of molecular biology, the most exciting aspect of AS1411 is a G-rich DNA oligonucleotide is its adaptability. Because it is a 26-mer G-rich DNA oligonucleotide, it is rela 作者：PJ Bates·2017·被引用次数：358—Background:AS1411 is a 26-mer G-rich DNA oligonucleotidethat forms a variety of G- quadruplex structures. It was identified based on its cancer-selective tively easy to modify with lipids or other polymers to adjust its kinetic properties.
Whether it is being used to develop new diagnostic tools or as a precision vehicle for delivery systems, the as1411 peptide continues to be a cornerstone of modern bio-nanotechnology. As research progresses, we are likely to see even more innovative uses for these G-quadruplex structures, pushing the boundaries of what is possible in targeted molecular science.
*Disclaimer: This article is for informational purposes only and describes scientific research and laboratory developments. I Nanoaggregate-forming lipid-conjugated AS1411 aptamer t does not provide medical advice, diagnosis, or treatment recommendations.*